Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · IEX Real-Time Price · USD
3.490
+0.010 (0.29%)
Jul 22, 2024, 10:24 AM EDT - Market open
Pyxis Oncology Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$9.83
Upside
+181.66%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +100.57% | May 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +186.53% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +100.57% | Apr 10, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +100.57% | Mar 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +100.57% | Mar 22, 2024 |
| BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +129.23% | Feb 9, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $12 | Buy | Initiates | $12 | +243.84% | Jan 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +14.61% | Nov 30, 2023 |
| RBC Capital | RBC Capital | Buy Initiates $7 | Buy | Initiates | $7 | +100.57% | Sep 5, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +329.80% | Jul 31, 2023 |
| Credit Suisse | Credit Suisse | Buy Reiterates $14 | Buy | Reiterates | $14 | +301.15% | Mar 23, 2023 |
| B of A Securities | B of A Securities | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 2, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 2, 2021 |
| Credit Suisse | Credit Suisse | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 2, 2021 |